Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
52.47
+1.26 (2.46%)
Aug 28, 2026, 4:00 PM EDT - Market closed
PBH Financials Overview
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,105 | 1,089 | 1,138 | 1,125 | 1,128 | 1,087 |
Revenue Growth | -1.36% | -4.31% | 1.10% | -0.21% | 3.76% | 15.21% |
Gross Profit Gross Profit Growth | 605.18 | 605.91 | 643.35 | 632.57 | 632.84 | 627.87 |
Operating Income Operating Income Growth | 293.01 | 309.41 | 349.24 | 342.43 | 347.8 | 336.08 |
Net Income Net Income Growth | 172.01 | 190.3 | 214.61 | 209.34 | -82.31 | 205.38 |
Earnings Per Share EPS Growth | 3.58 | 3.91 | 4.29 | 4.17 | -1.65 | 4.04 |
EPS Growth | -16.09% | -8.86% | 2.88% | - | - | 24.31% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
North American OTC Healthcare North American OTC Healthcare Growth | 927.2 | 913.58 | 960.01 | 958.26 | 973.77 | 967.88 |
International OTC Healthcare International OTC Healthcare Growth | 177.68 | 175.13 | 177.75 | 167.1 | 153.95 | 118.93 |
Revenue (Total) Revenue (Total) Growth | 1,105 | 1,089 | 1,138 | 1,125 | 1,128 | 1,087 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 89.13 | 63.87 | 97.88 | 46.47 | 58.49 | 27.19 |
Total Debt Total Debt Growth | 2,067 | 1,045 | 1,044 | 1,140 | 1,367 | 1,506 |
Net Cash (Debt) Net Cash Growth | -1,978 | -981.56 | -946.37 | -1,093 | -1,309 | -1,479 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -41.08 | -20.15 | -18.90 | -21.79 | -26.23 | -29.09 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 249.4 | 257.63 | 251.52 | 248.93 | 229.72 | 259.92 |
Capital Expenditures CapEx Growth | -14.04 | -11.18 | -8.22 | -9.55 | -7.78 | -9.64 |
Free Cash Flow Free Cash Flow Growth | 235.36 | 246.45 | 243.29 | 239.38 | 221.93 | 250.28 |
Free Cash Flow Growth | -12.13% | 1.30% | 1.64% | 7.86% | -11.33% | 17.30% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 54.77% | 55.65% | 56.55% | 56.21% | 56.12% | 57.77% |
Operating Margin | 26.52% | 28.42% | 30.70% | 30.43% | 30.84% | 30.92% |
Pretax Margin | 21.20% | 23.65% | 24.98% | 24.53% | -8.33% | 24.15% |
Profit Margin | 15.57% | 17.48% | 18.86% | 18.60% | -7.30% | 18.90% |
FCF Margin | 21.30% | 22.64% | 21.38% | 21.27% | 19.68% | 23.03% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.68 | 14.74 | 19.85 | 17.21 | - | 12.94 |
Forward PE | 11.18 | 12.58 | 17.90 | 15.89 | 14.53 | 12.82 |
P/FCF Ratio | 10.56 | 11.38 | 17.51 | 15.05 | 14.02 | 10.62 |
PS Ratio | 2.25 | 2.58 | 3.74 | 3.20 | 2.76 | 2.44 |